Erciyes Universitesi Tıp Fakultesi Hastaneleri

Kayseri 38039

0 studies enrolling now · 5 studies all time

What they study most

Active Nonsegmental Vitiligo, Advanced or Metastatic Breast Cancer, Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD), Multiple Myeloma, Stable Nonsegmental Vitiligo, Vitiligo

Studies at this site

• The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) — Running, not enrolling
• A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo — Running, not enrolling
• Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant — Running, not enrolling
• A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo — Completed
• A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment — Running, not enrolling